4D Molecular Therapeutics Inc (FDMT)
25.31
-0.33
(-1.29%)
USD |
NASDAQ |
May 17, 16:00
25.31
0.00 (0.00%)
After-Hours: 20:00
4D Molecular Therapeutics Price to Book Value: 2.179 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.207 |
| May 15, 2024 | 2.202 |
| May 14, 2024 | 2.217 |
| May 13, 2024 | 2.201 |
| May 10, 2024 | 2.213 |
| May 09, 2024 | 2.207 |
| May 08, 2024 | 2.267 |
| May 07, 2024 | 2.307 |
| May 06, 2024 | 2.304 |
| May 03, 2024 | 2.271 |
| May 02, 2024 | 2.247 |
| May 01, 2024 | 2.163 |
| April 30, 2024 | 2.038 |
| April 29, 2024 | 2.066 |
| April 26, 2024 | 1.980 |
| April 25, 2024 | 2.004 |
| April 24, 2024 | 2.066 |
| April 23, 2024 | 2.113 |
| April 22, 2024 | 2.248 |
| April 19, 2024 | 2.151 |
| April 18, 2024 | 2.111 |
| April 17, 2024 | 2.155 |
| April 16, 2024 | 2.279 |
| April 15, 2024 | 2.236 |
| April 12, 2024 | 2.245 |
| Date | Value |
|---|---|
| April 11, 2024 | 2.360 |
| April 10, 2024 | 2.294 |
| April 09, 2024 | 2.308 |
| April 08, 2024 | 2.449 |
| April 05, 2024 | 2.436 |
| April 04, 2024 | 2.354 |
| April 03, 2024 | 2.378 |
| April 02, 2024 | 2.383 |
| April 01, 2024 | 2.556 |
| March 31, 2024 | |
| March 28, 2024 | 5.152 |
| March 27, 2024 | 5.800 |
| March 26, 2024 | 5.506 |
| March 25, 2024 | 5.433 |
| March 22, 2024 | 5.433 |
| March 21, 2024 | 5.466 |
| March 20, 2024 | 5.417 |
| March 19, 2024 | 5.178 |
| March 18, 2024 | 5.018 |
| March 15, 2024 | 5.095 |
| March 14, 2024 | 4.749 |
| March 13, 2024 | 4.754 |
| March 12, 2024 | 4.614 |
| March 11, 2024 | 4.617 |
| March 08, 2024 | 4.782 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6197
Minimum
Jun 16 2022
17.88
Maximum
Dec 18 2020
2.787
Average
2.614
Median
Mar 31 2023
Price to Book Value Benchmarks
| Ionis Pharmaceuticals Inc | 18.37 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7501 |
| Theriva Biologics Inc | 0.2114 |
Price to Book Value Related Metrics
| PS Ratio | 53.44 |
| Price | 25.31 |
| Earnings Yield | -9.64% |
| Market Cap | 1.309B |